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Abstract
Background: Proposed draft diagnostic criteria for the fifth edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM-5) suggest that dimensional assessments can supplement dichotomous diagnoses by
incorporating measures of severity, frequency, and duration, providing the ability to monitor changes in symptoms
over time and to guide appropriate treatment.
Methods: This report is based on data from the Behavioral Risk Factor Surveillance System 2006 from 198,678
survey participants who responded to all eight Patient Health Questionnaire (PHQ-8) items. We evaluated use of
the days version of the PHQ-8 to determine an optimal cut-point for identifying respondents with depression and
to evaluate the performance characteristics of the PHQ-8 at this cut-point.
Results: A PHQ-8 score of 55 or more days was determined to be the optimal cut-point when compared to the
DSM-derived PHQ-8 algorithm for a major depressive episode (five or more symptoms present “more than half the
days,” at least one of which must be anhedonia or depression). In the full sample, the sensitivity and the specificity
of this cut-point were 0.91 (0.90-0.93) and 0.99 (0.99-0.99), respectively.
Conclusion: The days version of the PHQ-8 may be a valuable dimensional alternative to the traditional PHQ-8 by
offering finer granularity of dimensionality (a score of 0 to 112).
Background
Diagnostic and Statistical Manual of Mental Disorders
(DSM) criteria are presently designed to establish cate-
gorical diagnoses, distinguishing those with a particular
mental disorder from those without such a disorder [1].
DSM criteria are currently less useful for measuring psy-
chiatric symptoms and disorders on a continuum. Major
depressive disorder is classified as a mood disorder, with
diagnosis hinging on the presence of a single episode or
of recurrent major depressive episodes (MDE) [1]. The
gold standard for a diagnosis of depression is the Struc-
tural Clinical Interview (SCID), a diagnostic interview
based on DSM criteria that requires clinical expertise to
administer. It yields a dichotomous outcome, the pre-
sence or absence of MDE, for the past month (current),
past year, or over a lifetime, based on the presence of
five or more of the nine DSM criteria, provided that
anhedonia or depression was present [1,2].
The proposed draft diagnostic criteria for the fifth edi-
tion of the DSM (DSM-5; http://www.dsm5.org) suggest
that graded, dimensional assessments can supplement
dichotomous diagnoses. Furthermore, dimensional
assessments incorporating measures of severity, fre-
quency, and duration may help psychiatric research, epi-
demiology, and clinical services to not only better
monitor changes in respondents’ symptoms over time
but also to guide the choice of appropriate population
and clinical interventions [3]. Categorical and dimen-
sional approaches are fundamentally equivalent with no
one right approach. Advocates of both approaches may
well be right, but in different circumstances [4,5].
Given the time and expense required to administer the
SCID, epidemiological studies instead use either struc-
tured interviews designed for trained lay interviewers
(e.g., the Composite International Diagnostic Interview
[CIDI], the Diagnostic Interview Schedule [DIS]) or self-
report questionnaires [6-8]. Such self-report question-
naires (e.g., the Center for Epidemiologic Studies of
Depression Scale [CES-D], versions of the Patient Health
Questionnaire [PHQ-9, PHQ-8], the Beck Depression
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Inventory [BDI], and other measures) [9-11] measure
symptoms and mood to provide evidence for a disorder
(defined as “something wrong with a patient that is of
clinical significance”) rather than for a diagnosis (defined
as “an expert opinion that a disorder is present”) [4].
Nonetheless, self-report questionnaires such as the 9-
item (PHQ-9) and the 8-item (PHQ-8) Patient Health
Questionnaire depression measure can provide a dimen-
sional assessment for depression because they are scored
by summing how often a number of typical depressive
symptoms occur [5,9]. A PHQ-8 score of ≥10 can also
yield a categorical diagnosis of clinically significant
depression and is more convenient to use than a DSM-
IV diagnostic algorithm [9].
A recent revision to the PHQ-8 (referred to as the
PHQ-8 Days) used in the Behavioral Risk Factor Surveil-
lance System (BRFSS) survey adds further dimensional-
ity to the PHQ-8 by asking the number of days in the
past 14 days the respondent experienced each of the
eight depressive symptoms, yielding 0 to 112 total days
[12]. In this study, we determine the optimal cut-point
of the PHQ-8 Days scale for identifying respondents
experiencing major depression during the past two
weeks, and then evaluate the performance characteristics
of the PHQ-8 Days at this cut-point. We estimate the
robustness of its receiver operating characteristic (ROC)
curve and compare the prevalence of major depression
at this cut-point (positive test frequency) with that
based on the proportion of PHQ-8 respondents meeting
the DSM algorithm criteria for MDE. We also demon-
strate the fine granularity of the PHQ-8 Days scale by
lifetime diagnosis of anxiety and depression and multiple
domains of health-related quality of life. Assessment of
the PHQ-8 Days scale in this large epidemiological
study may provide further evidence of its utility as a
dimensional measure of depression in population-based
research.
Methods
Behavioral Risk Factor Surveillance System survey (BRFSS)
We analyzed data from the 2006 BRFSS survey. The
BRFSS is a population-based, state surveillance system
using ongoing, random-digit-dialed telephone surveys of
noninstitutionalized US residents aged 18 years or older
that monitors the prevalence of key health- and safety-
related behaviors and characteristics [13,14]. During the
2006 survey, trained interviewers in 41 states and terri-
tories administered the Anxiety and Depression Module,
which includes the PHQ-8 [12]. Weighting of BRFSS
data is designed to make the total number of cases
equal to the number of people in the state who are age
18 and older. In the BRFSS, such post-stratification
serves as an adjustment for noncoverage and nonre-
sponse and forces the total number of cases to equal
population estimates for each geographic region, usually
a state for the BRFSS. The median response rate among
all states and territories, based on Council of American
Survey and Research Organizations (CASRO) guidelines,
was 51.4% (range: 35.1%-66.0%) in 2006, 50.6% (range:
26.9%-65.4%) in 2007, and 53.3% (range: 35.8%-65.9%)
in 2008. The median cooperation rate was 74.5% (range:
56.9%-83.5%) in 2006, 72.1% (range: 49.6%-84.6%) in
2007, and 75.0% (range: 59.3%-87.8%) in 2008. Surveil-
lance methodology, design, implementation, and
response rates are available at: http://www.cdc.gov/brfss/
technical_infodata/2002QualityReport and http://www.
cdc.gov/BRFSS/technical_infodata/index.htm.
There were 198,678 respondents from the 38 states,
Washington, DC, Puerto Rico, and the US Virgin Islands
who completed all of the PHQ-8.
Measures
Patient Health Questionnaire eight-item depression scale
(PHQ-8)
The PHQ-8 response set was standardized to make it
similar to other BRFSS questions by asking the number
of days in the past two weeks the respondent had
experienced each of the eight out of nine DSM criteria
symptoms. In previous BRFSS analyses, the modified
response set had been converted back to the original
response set: 0 to 1 day = ‘not at all,’ 2 to 6 days = ‘sev-
eral days,’ 7 to 11 days = ‘more than half the days,’ and
12 to 14 days = ‘nearly every day,’ with points (0 to 3)
assigned to each category, respectively [12]. The scores
for each item are summed to produce a total score
between 0 and 24 points. A total score of 0 to 4 repre-
sents no significant depressive symptoms; 5 to 9, mild
symptoms; 10 to 14, moderate symptoms; 15 to 19,
moderately severe symptoms; and 20 to 24, severe
symptoms [9]. Current depression is defined in two
ways: 1) a PHQ-8 DSM-derived algorithm diagnosis of
major depression (≥ five symptoms present ‘more than
half the days,’ with at least one symptom being anhedo-
nia or depression) or other depression (two to four
symptoms, including depressed mood or anhedonia, are
required to be present ‘more than half the days’); 2) a
PHQ-8 score of ≥10, which has an 88% sensitivity and
88% specificity for major depression, and, regardless of
diagnostic status, typically represents clinically signifi-
cant depression [9].
Lifetime diagnosis of anxiety or depressive disorders
Two questions were asked about lifetime diagnosis: “Has
a doctor or other health care provider ever told you that
you have an anxiety disorder (including acute stress dis-
order, anxiety, generalized anxiety disorder, obsessive-
compulsive disorder, panic attacks, panic disorder, pho-
bia, post-traumatic stress disorder, or social anxiety
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disorder)?” and “Has a doctor or other health care pro-
vider ever told you that you have a depressive disorder
(including depression, major depression, dysthymia, or
minor depression)?”
Health-related quality of life and other items
Three health-related quality of life (HRQoL) questions
with demonstrated validity and reliability for population
health surveillance were examined [15-17]. The three
questions involved respondents’ self-assessment of their
health over the previous 30 days:
1) Physical health: “How many days was your physical
health, which includes physical illness or injury, not
good?”
2) Mental health: “How many days was your mental
health, which includes stress, depression, and problems
with emotions, not good?”
3) Activity limitations: “Are you limited in any way in
any activities because of physical, mental, or emotional
problems?”
Sociodemographic characteristics
Sociodemographic information was obtained for each
respondent. We assessed the extent to which seven
sociodemographic characteristics (sex, age, race, educa-
tion, employment status, annual household income, and
marital status) were associated with major depression as
determined by participants’ responses to the PHQ-8.
Analysis
In this study, the condition of interest is MDE as
defined by DSM-IV-derived PHQ-8 algorithm “gold
standard” criteria (five or more depressive symptoms
present ‘more than half the days,’ and at least one of
which must be anhedonia or depression). Sensitivity is
the proportion of persons with this condition ascer-
tained by a test to have that condition. Specificity is the
proportion of persons without this condition ascertained
by a test not to have the condition. Youden’s J index
(YJI), one measure of combined test validity, is the sum
of the sensitivity and the specificity minus 1. The test is
the PHQ-8 Days cut-point with the highest simulta-
neous values for sensitivity and specificity (maximum
YJI) among respondents indicating ≥ seven days of
either anhedonia or depression (n = 22,542).
We ascertained this cut-point by converting all BRFSS
weights to integer weights to obtain the ROC curve and
area under the curve (AUC) over the range of test
values (0 to 112 days). The ROC curve summarizes test
validity measures over the range of the test values and
plots the sensitivity of the test on the vertical axis versus
(1 - specificity) on the horizontal axis. The AUC is a
measure of accuracy of a test instrument, with AUCs
between 0.5 and 0.7 considered as reflecting low
accuracy; between 0.7 and 0.9, moderate accuracy; and
those above 0.9, high accuracy [15].
We assessed the prevalence of major depression by (a)
using this PHQ-8 Days cut-point and (b) according to
the DSM-derived PHQ-8 algorithm criteria for MDE by
sex, age, race, education, employment status, annual
income, and marital status. We also estimated the mean
number of PHQ-8 Days by three measures of HRQoL
and lifetime diagnosis of anxiety and depression. We
used SPSS, Version 17.0 (SPSS Inc., Chicago, IL) with
the complex sampling module for all analyses.
Results
A PHQ-8 score of 55 or more days was determined to
be the optimal cut-point when compared to the DSM-
derived PHQ-8 MDE algorithm (≥ five symptoms pre-
sent ‘more than half the days’ and at least one of which
must be anhedonia or depression). While the Youden’s J
Index was similar (0.836) over a narrow range of cut-
points from 53 to 56, a cut-point of 55 or higher was
selected (Table 1). AUC for the range of the test values
(0-112) was 0.98 (Figure 1). Among the full sample of
198,678 people who responded to all eight PHQ-8 ques-
tions, the sensitivity and the specificity of a PHQ-8 Days
cut-point of 55 or higher were 0.91 (0.90-0.93) and 0.99
(0.99-0.99), respectively.
The prevalence estimates of MDE, based on the PHQ-
8 Days optimal cut-point of 55 or more days, did not
differ statistically significantly from the prevalence esti-
mates of DSM-derived PHQ-8 MDE by sex, age, race,
education, employment status, annual income, and mari-
tal status (Table 2).
Table 1 Operating characteristics of the number of PHQ-8
Days (range: 0 to 112 days) for identifying a major
depressive episode as defined by DSM-IV-derived PHQ-8
criteria†
PHQ-8 Days Sensitivity Specificity Youden’s J Index
<50 ≥0.969 ≤0.849 0.818
≥50 0.955 0.868 0.823
≥51 0.945 0.882 0.827
≥52 0.936 0.892 0.828
≥53 0.929 0.907 0.836
≥54 0.923 0.913 0.836
≥55 0.913 0.922 0.835
≥56 0.904 0.932 0.836
≥57 0.882 0.953 0.835
≥58 0.874 0.960 0.834
≥59 0.863 0.966 0.829
≥60 ≤0.850 ≥0.972 0.822
†DSM-IV-derived PHQ-8 criterion: ≥ 5 symptoms present ‘more than half the
days’ and at least one of which must be anhedonia or depression. Operating
characteristics determined in respondents indicating ≥ 7 days of either
anhedonia or depression (n = 22,542).
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Respondents with disabilities reported more than
twice as many PHQ-8 Days, 25.8 (25.2-26.3), as respon-
dents without disability, 10.3 (10.1-10.5; Table 3). As the
number of mentally unhealthy days (Table 4) and physi-
cally unhealthy days (Table 5) increased, mean PHQ-8
Days and the weighted prevalence of major depression
also increased.
Mean PHQ-8 Days increased markedly with changes
in current depression status (none, other, and major)
and in lifetime depression status (No to Yes) but not
with changes in lifetime anxiety status (No to Yes)
except in those without current depression (Table 6).
Discussion
To the best of our knowledge, this is the first study to
examine and extend the proposed DSM-5 dimensional-
ity available using PHQ-8 in its current response format.
A PHQ-8 Days cut-point of 55 or more days (provided
anhedonia or depression was present seven or more
days) best identified respondents with MDE derived
from a DSM-based PHQ-8 algorithm. AUC for the
range of test values reflected high accuracy [18]. Preva-
lence estimates of MDE based on the cut-point of 55 or
more days were not statistically significantly different
from those derived from the DSM-based PHQ-8 algo-
rithm when stratified by seven sociodemographic char-
acteristics. Prevalence estimates of MDE, based on the
cut-point of 55 or more days for all categories of socio-
demographic characteristics examined, were higher than
those of MDE derived from the DSM-based PHQ-8
algorithm, except for no difference in prevalence among
homemakers. Prevalence estimates at 56 or more days
would have been closer to the DSM-derived MDE algo-
rithm estimates. It is noteworthy that beyond two
weeks, MDE prevalence estimates from the BRFSS of
4.4% and 4.2%, based on the cut-point of 55 days or
more and from the DSM-based PHQ-8 algorithm,
respectively, are in close proximity to prevalence rates
of past 30-day major depression found in other studies
and in a systematic review of the literature [19-21].
Besides the robust operating characteristics of PHQ-8
Days at the cut-point of 55 or more days, this study had
other key findings. First, even among respondents with-
out current depression, mean PHQ-8 Days increased
significantly in a stepwise manner from 7.6 days (7.4-
7.7) for respondents without lifetime depression or anxi-
ety to 20.8 days (20.1-21.4) for respondents with lifetime
depression and anxiety. Among respondents with cur-
rent other or current major depression, a lifetime his-
tory of depression but not anxiety increased mean
PHQ-8 days statistically significantly. Second, the
dimensional scale of PHQ-8 days increased with both
physically and mentally unhealthy days, especially with
the latter. Mean PHQ-8 Days increased from about nine
days at a level of 0 physically unhealthy days to 28 days
at 11-15 physically unhealthy days and to 34 days at 21-
30 physically unhealthy days. Mean PHQ-8 days
increased from about 8 days at 0 mentally unhealthy
days to 33 days at 11-15 mentally unhealthy days and to
44 days at 21-30 mentally unhealthy days.
The PHQ-8 Days version may be a valuable dimen-
sional alternative to the traditional PHQ in several
respects for psychiatric epidemiology and clinical ser-
vices. First, its finer granularity (scores from 0 to 112
for PHQ-8 vs. 0 to 24; or 0 to 126 for PHQ-9 vs. 0 to
27) may increase sensitivity to change when monitoring
depression longitudinally in clinical trials or cohort stu-
dies. Second, a quantitative response format ("number of
days”) and a standardized recall period provide greater
uniformity and ease of translation, whereas the current
verbal response options such as “several,” “more than
half,” or “nearly every day” may be more susceptible to
variable interpretations when translated into different
languages or used across multiple cultures. Third, the
Figure 1 Receiver Operating Characteristic (ROC) curve plotted
for Sensitivity and 1 - Specificity for each number of PHQ-8
Days (0 to 112 days) in identifying respondents indicating ≥ 7
days of either anhedonia or depression (n = 22,542), with
major depressive episode (MDE) as defined by a DSM-IV-
derived PHQ-8 criteria of ≥ 5 symptoms present ‘more than
half the days’ and at least one of which must be anhedonia or
depression.
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Table 2 Prevalence of current major depressive episode according to DSM-IV-derived PHQ-8 criterion† and the
















Unweighted n 198,678 8,476 8,970
Overall 4.2 4.0 - 4.4 4.4 4.2 - 4.6
Sex
Female 122,390 4.9 4.7 - 5.2 5.2 4.9 - 5.5
Male 76,288 3.4 3.1 - 3.7 3.5 3.2 - 3.8
Age
18 - 24 9,186 3.7 3.1 - 3.4 4.0 3.3 - 4.7
25 - 34 24,493 4.3 3.8 - 4.9 4.6 4.0 - 5.2
35 - 44 34,910 4.7 4.2 - 5.2 4.8 4.3 - 5.3
45 - 54 42,321 5.2 4.8 - 5.7 5.4 5.0 - 5.9
55 - 64 39,235 4.7 4.2 - 5.2 4.9 4.4 - 5.4
≥65 47,161 2.1 1.8 - 2.4 2.3 2.1 - 2.6
Race/ethnicity
White 153,642 3.9 3.7 - 4.1 4.0 3.8 - 4.3
Black 15,819 4.8 4.2 - 5.4 5.2 4.6 - 5.8
Hispanic 15,602 4.7 4.0 - 5.5 4.9 4.2 - 5.7
Other 11,955 5.3 4.5 - 6.4 5.6 4.7 - 6.7
Education
<High school 18,776 8.1 7.2 - 9.1 8.7 7.8 - 9.6
High school 58,191 5.0 4.6 - 5.3 5.2 4.9 - 5.6




96,650 2.4 2.2 - 2.7 2.6 2.4 - 2.9
Self-employed 18,924 2.7 2.2 - 3.4 2.8 2.3 - 3.5
Out of work >1
year
3,242 13.8 11.6 - 16.3 14.2 12.1 - 16.7
Out of work <1
year
4,106 9.6 8.0 - 11.5 10.2 8.6 - 12.0
Homemaker 15,848 3.9 3.3 - 4.6 3.9 3.3 - 4.6
Student 4,053 3.8 2.7 - 5.2 3.7 2.7 - 5.2
Retired 44,496 2.1 1.9 - 2.4 2.3 2.1 - 2.6
Unable to work 11,006 26.8 24.9 - 28.7 28.4 26.5 - 30.3
Marital status
Married 112,779 2.9 2.7 - 3.1 3.0 2.8 - 3.2
Divorced 28,362 8.3 7.7 - 9.1 8.7 8.0 - 9.5
Widowed 22,173 5.1 4.4 - 6.0 5.4 4.7 - 6.3
Separated 4,440 12.0 10.1 - 14.2 12.7 10.8 - 15.0




5,236 5.7 4.5 - 7.1 6.3 5.0 - 7.9
†DSM-IV-derived PHQ-8 criterion: ≥ 5 symptoms present ‘more than half the days’ and at least one of which must be anhedonia or depression.
‡Major depression PHQ-8 Days algorithm: 55 or more PHQ-8 Days.
Table 3 Mean number of PHQ-8 Days by disability ("Are you limited in any way in any activities because of physical,
mental, or emotional problems?”)
Disability status Unweighted (n) Weighted proportion (%) 95% Confidence Interval Mean PHQ-8 Days 95% Confidence Interval
No 151,546 80.1 79.7 - 80.5 10.3 10.1 - 10.5
Yes 46,559 19.9 19.5 - 20.3 25.8 25.2 - 26.3
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current verbal response set using these less well-defined
words and phrases is only an ordinal level, not an inter-
val level, of measurement. Fourth, entering the number
of days is easier to use in automated data gathering
such as interactive voice recorded (IVR) calls. A poten-
tial disadvantage of using “number of days” is that some
respondents may not be able to provide a specific num-
ber of days so that an interviewer may have to interpret
what the respondent reply means or to interpolate when
the respondent provides a range rather than a discrete
number.
Some of these as well as other factors make the PHQ-
8 Days version a useful option for public health research
and surveillance. Individuals assessed in the general
population typically have fewer and less severe depres-
sive symptoms than patients evaluated in clinical set-
tings; in this case, the greater range of the PHQ-8 Days
version might make it more sensitive to subthreshold
symptoms, with fewer concerns about a floor effect.
Besides being valuable for capturing the full spectrum of
depressive symptoms in the general population, this fea-
ture may also be useful in detecting low levels of symp-
toms that may occur in the wake of man-made or
natural disasters and in monitoring mental health fol-
lowing such traumatic events. The reduction in cultural
and language variability with the quantitative response
set and the greater ease-of-use with automated data
gathering may be particularly useful for large popula-
tion-based surveys.
Key strengths of this study are that the survey popula-
tions in participating states were reasonably representa-
tive of the state populations and that sample sizes were
large enough to analyze positive test frequency in seven
sociodemographic subgroups. Although the PHQ-8 was
used in the BRFSS, the concept of PHQ days can likely
be applied to the PHQ-9 as well. The cut-points on the
PHQ-8 and PHQ-9 are identical, and either is a valid
measure of depression severity [22,23]. The PHQ-8
omits the ninth item of the PHQ-9 (which asks about
thoughts of death or self-harm) and is often used in epi-
demiological studies where professional follow-up is
unavailable or impractical, and in clinical research stu-
dies where depression is a secondary rather than pri-
mary outcome. Almost all of the positive responses to
this ninth item represent passive thoughts of death
rather than suicidal ideation.
Studies based on BRFSS data in general and the
depression and anxiety module in particular have some
inherent limitations. First, they are representative of
only households with landline telephones included in
BRFSS surveys. If respondents in currently excluded
households without telephones or with only cell
phones answer the PHQ-8 Days questions differently
from respondents in households with landline tele-
phones, the prevalence estimates of MDE may be
biased compared to that from interviews in all house-
holds, but this difference should not affect the test
validity of the PHQ-8 Days measure proposed here.























0 133,812 65.8 65.3 - 66.2 7.7 7.6 - 7.9 0.6 0.5 - 0.7
1 - 6 38,119 19.0 18.6 - 19.4 13.9 13.5 - 14.3 1.8 1.5 - 2.2
7 - 10 9,279 4.7 4.5 - 4.9 24.2 23.0 - 25.3 8.3 7.1 - 9.6
11 - 15 6,804 3.3 3.1 - 3.5 33.4 31.9 - 34.9 16.7 14.6 - 19.1
16 - 20 2,870 1.4 1.3 - 1.6 41.2 39.3 - 43.2 25.0 21.8 - 28.5
21 - 30 13,609 5.8 5.6 - 6.0 49.2 47.9 - 50.5 37.3 35.4 - 39.3
























0 141,421 64.4 63.9 - 64.9 9.4 9.3 - 9.6 1.9 1.7 - 2.1
1 - 6 41,479 20.4 20.1 - 20.8 14.6 14.1 - 15.0 3.6 3.2 - 4.1
7 - 10 9,553 4.1 3.9 - 4.2 21.1 20.1 - 22.0 8.0 6.9 - 9.3
11 - 15 7,059 3.0 2.8 - 3.1 27.6 26.0 - 29.2 12.8 11.0 - 15.0
16 - 20 2,658 1.1 1.0 - 1.2 32.0 29.7 - 34.2 14.8 12.3 - 17.7
21 - 30 19,664 7.0 6.8 - 7.2 34.1 32.8 - 35.3 20.1 18.7 - 21.6
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Second, because BRFSS data are based on subjective
responses of survey participants, recall bias and biases
related to the perceived social desirability of certain
responses may affect their accuracy. Third, BRFSS and
the “gold standard” DSM diagnostic algorithm for
MDE to which the PHQ-8 Days version is compared
are unable to address both the inclusion criteria for
symptoms that cause clinically significant distress or
impairment in social, occupational, or other important
areas of functioning and the exclusion criteria for epi-
sodes due to the direct physiological effects of a sub-
stance or antidepressant intervention (e.g., a drug of
abuse, a medication, or other treatment). Furthermore,
the BRFSS and this “gold standard” do not account for
those being successfully treated and asymptomatic at
the time of the survey. Despite these limitations, other
BRFSS estimates have been shown to be valid and reli-
able when compared with estimates derived from
national household survey data [24,25]. BRFSS surveys
are a cost-effective and timely means of collecting
state and local data, and BRFSS data are often the only
data source with which states and communities can
assess local health conditions and track progress
toward improving those conditions.
We have demonstrated the ease of using the PHQ-8
Days responses not only to create a highly granular
dimensional measure but also to identify a categorical
cut-point for major depressive episode. Additional cut-
points for other categories of depression severity could
easily be identified, giving the psychiatric epidemiologi-
cal and services community the much-needed granular-
ity and flexibility to detect changes and help monitor
changes in respondents’ symptoms over time as well as
providing additional data to help guide the choice of
appropriate interventions [3].
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